Lei Dong

1.5k total citations
41 papers, 1.0k citations indexed

About

Lei Dong is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Lei Dong has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 11 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Lei Dong's work include Autophagy in Disease and Therapy (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Tyrosine Phosphatases (6 papers). Lei Dong is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Tyrosine Phosphatases (6 papers). Lei Dong collaborates with scholars based in China, United States and France. Lei Dong's co-authors include Xia Qin, Liqun Liu, Yu Zhu, Xiaobo Li, Shouwei Li, Feng Ren, Pei Zhang, Ping Yang, Zhi‐Jun Qiu and Guang Li and has published in prestigious journals such as Nature, Oncogene and Scientific Reports.

In The Last Decade

Lei Dong

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lei Dong China	15	702	376	183	167	144	41	1.0k
Francesca Pedini Italy	14	626 0.9×	426 1.1×	177 1.0×	180 1.1×	117 0.8×	21	973
Manoj M. Pillai United States	18	557 0.8×	236 0.6×	141 0.8×	231 1.4×	133 0.9×	39	897
Karl X. Knaup Germany	18	528 0.8×	442 1.2×	145 0.8×	123 0.7×	63 0.4×	29	1.1k
Leire Gárate Spain	23	1.2k 1.7×	573 1.5×	106 0.6×	154 0.9×	114 0.8×	32	1.5k
Chiqi Chen China	17	479 0.7×	244 0.6×	180 1.0×	142 0.9×	65 0.5×	34	792
Edurne San José‐Eneriz Spain	24	1.4k 2.0×	596 1.6×	110 0.6×	166 1.0×	153 1.1×	39	1.7k
Charlotte E. Edling United Kingdom	14	606 0.9×	124 0.3×	136 0.7×	273 1.6×	93 0.6×	32	1.0k
Ka-Kei Ho United Kingdom	8	595 0.8×	288 0.8×	87 0.5×	172 1.0×	82 0.6×	8	978
Vanessa Desantis Italy	19	580 0.8×	175 0.5×	178 1.0×	282 1.7×	59 0.4×	44	955

Countries citing papers authored by Lei Dong

Since Specialization

Citations

This map shows the geographic impact of Lei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Dong more than expected).

Fields of papers citing papers by Lei Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Dong. The network helps show where Lei Dong may publish in the future.

Co-authorship network of co-authors of Lei Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Dong. A scholar is included among the top collaborators of Lei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Dong. Lei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Lei, Jiyan Dai, Xiao Ouyang, et al.. (2025). The interconnective role of the UPS and autophagy in the quality control of cancer mitochondria. Cellular and Molecular Life Sciences. 82(1). 42–42. 4 indexed citations

Sun, Yanan, Dong Zheng, Qiang Li, et al.. (2025). Analysis of the impact of CO2 injection on fracturing fluid flowback in shale gas wells. Scientific Reports. 15(1). 34223–34223.

Wang, Wenyu, et al.. (2025). Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI. Metabolites. 15(3). 201–201. 8 indexed citations

Qin, Xia, et al.. (2024). SMURF1 mediates damaged lysosomal homeostasis by ubiquitinating PPP3CB to promote the activation of TFEB. Autophagy. 21(3). 530–547. 2 indexed citations

Li, Xiaoyu, et al.. (2024). The Regenerative Microenvironment of the Tissue Engineering for Urethral Strictures. Stem Cell Reviews and Reports. 20(3). 672–687. 2 indexed citations

Qin, Xia, Yang Li, Wanting Xu, et al.. (2023). SMURF1 controls the PPP3/calcineurin complex and TFEB at a regulatory node for lysosomal biogenesis. Autophagy. 20(4). 735–751. 8 indexed citations

Dong, Lei, Mengchuan Xu, Yang Li, et al.. (2023). SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway. Cell Death and Disease. 14(6). 361–361. 11 indexed citations

Qin, Xia, Wenxuan Li, Sakhawat Ali, et al.. (2021). Smurf1 silencing restores PTEN expression that ameliorates progression of human glioblastoma and sensitizes tumor cells to mTORC1/C2 inhibitor Torin1. iScience. 24(12). 103528–103528. 6 indexed citations

Dong, Lei, et al.. (2021). Activating Mutation of SHP2 Establishes a Tumorigenic Phonotype Through Cell-Autonomous and Non-Cell-Autonomous Mechanisms. Frontiers in Cell and Developmental Biology. 9. 630712–630712. 21 indexed citations

10.

Ali, Sakhawat, Xia Qin, Tahir Muhammad, et al.. (2021). Glioblastoma Therapy: Rationale for a Mesenchymal Stem Cell-based Vehicle to Carry Recombinant Viruses. Stem Cell Reviews and Reports. 18(2). 523–543. 17 indexed citations

11.

Qin, Xia, Hanwen Zhang, Pei Zhang, et al.. (2020). Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation. Oncogene. 39(36). 5902–5915. 30 indexed citations

12.

Dong, Lei, Shuo You, Qing Zhang, et al.. (2018). Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma. Clinical Cancer Research. 25(7). 2206–2218. 52 indexed citations

13.

Xu, Ke, Guo Chen, Xiaobo Li, et al.. (2017). MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling. Scientific Reports. 7(1). 41718–41718. 107 indexed citations

14.

Li, Xiaobo, Lei Dong, Weiren Xu, et al.. (2016). Study of SHP-2 ( PTPN11 ) allosterism on structural movement using solution perturbed molecular dynamics simulation. Journal of Molecular Liquids. 223. 509–515. 6 indexed citations

15.

Dong, Lei, Wen-Mei Yu, Hong Zheng, et al.. (2016). Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature. 539(7628). 304–308. 189 indexed citations

16.

Wang, Meiyan, Xiaobo Li, Lei Dong, et al.. (2016). Virtual screening, optimization, and identification of a novel specific PTP-MEG2 Inhibitor with potential therapy for T2DM. Oncotarget. 7(32). 50828–50834. 6 indexed citations

17.

Ren, Feng & Lei Dong. (2015). Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.. PubMed. 8(6). 6107–16. 25 indexed citations

18.

Liu, Tao, Xiaobo Li, Shuo You, Soumitra S. Bhuyan, & Lei Dong. (2015). Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice. Experimental Hematology and Oncology. 5(1). 19–19. 47 indexed citations

19.

Dong, Lei, Xiaopeng Zhang, Jun Ren, et al.. (2013). Human Prostate Stem Cell Antigen and HSP70 Fusion Protein Vaccine Inhibits Prostate Stem Cell Antigen-Expressing Tumor Growth in Mice. Cancer Biotherapy and Radiopharmaceuticals. 28(5). 391–397. 5 indexed citations

20.

Dong, Lei, et al.. (2013). Expressions of Src homology 2 domain-containing phosphatase and its clinical significance in laryngeal carcinoma. Genetics and Molecular Research. 12(4). 4207–4212. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact